UnitedHealth wins favorable ruling against US fraud case

Reuters
Yesterday
UnitedHealth wins favorable ruling against US fraud case

By Brendan Pierson

March 4 (Reuters) - A court-appointed special master has found that U.S. authorities do not have evidence to support their billion-dollar fraud case accusing UnitedHealth Group UNH.N of keeping overpayments from the government for patients on its Medicare insurance plans.

The recommendation by Special Master Suzanne Segal on Monday is not a final ruling, but if it is adopted by U.S. District Judge Fernando Olguin, it would end the U.S. Department of Justice's claims against the health insurer.

"After more than a decade of DOJ’s wasteful and expensive challenge to our Medicare Advantage business, the Special Master concluded there was no evidence to support the DOJ’s claims we were overpaid or that we did anything wrong," UnitedHealth said in a statement.

The Justice Department did not immediately respond to a request for comment.

The government claimed in its 2016 lawsuit that UnitedHealth submitted false diagnoses for patients on its government-funded, privately administered Medicare Advantage plans in order to get higher payments. Medicare reimbursements to insurers that administer Medicare Advantage plans are tied to patients' diagnosis codes, with sicker patients getting higher reimbursements.

However, Segal wrote on Monday that the government's case relied on discrepancies between diagnoses submitted by doctors making claims and later determinations by UnitedHealth's coders. She said that did not show that any of the original claims were false, concluding that there "simply was no fraud."

(Reporting by Brendan PiersonEditing by Bill Berkrot)

((646-306-0235))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10